Iatrogenic immunosuppression and cutaneous malignancy

Jennifer L. DePry, Kurtis B. Reed, Robert H. Cook-Norris, Jerry D. Brewer

Research output: Contribution to journalArticle

31 Scopus citations


Patients with autoimmune and inflammatory conditions often receive long-term immunosuppressive therapy. Some of the largest patient populations with iatrogenic immunosuppression include patients who have received solid-organ transplants or who have rheumatoid arthritis or psoriasis. Although treatments improve patient outcomes, individuals with immunosuppression subsequently may have an increased risk of skin cancer, including squamous cell carcinoma, basal cell carcinoma, and malignant melanoma.

Original languageEnglish (US)
Pages (from-to)602-613
Number of pages12
JournalClinics in Dermatology
Issue number6
StatePublished - Nov 2011


ASJC Scopus subject areas

  • Dermatology

Cite this

DePry, J. L., Reed, K. B., Cook-Norris, R. H., & Brewer, J. D. (2011). Iatrogenic immunosuppression and cutaneous malignancy. Clinics in Dermatology, 29(6), 602-613. https://doi.org/10.1016/j.clindermatol.2011.08.009